Cargando…
Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
Bronchiolitis obliterans syndrome (BOS) is a life-threatening pulmonary manifestation of chronic graft versus host disease (cGVHD) post-allogeneic hematopoietic stem cell transplantation (HSCT), without clear standard of care. This study included 30 patients undergoing an allogeneic HSCT for a hemat...
Autores principales: | Zhao, Yanmin, OuYang, Guifang, Shi, Jimin, Luo, Yi, Tan, Yamin, Yu, Jian, Fu, Huarui, Lai, Xiaoyu, Liu, Lizhen, Huang, He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273229/ https://www.ncbi.nlm.nih.gov/pubmed/34262450 http://dx.doi.org/10.3389/fphar.2021.668825 |
Ejemplares similares
-
Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Hengwei, et al.
Publicado: (2021) -
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
por: Afram, Gabriel, et al.
Publicado: (2018) -
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
por: Bergeron, A, et al.
Publicado: (2012) -
Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
por: Shokouhi, Shabnam, et al.
Publicado: (2015) -
Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kim, Yu Ri, et al.
Publicado: (2012)